BioStem Technologies, Inc.

Healthcare · Biotechnology · United States

Last price 1.12 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 20.81M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a hu...